American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$272M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$237M |
| 3 |
Kenvue
KVUE
|
+$236M |
| 4 |
Norfolk Southern
NSC
|
+$219M |
| 5 |
Amazon
AMZN
|
+$173M |
Top Sells
| 1 |
Marvell Technology
MRVL
|
+$230M |
| 2 |
Walt Disney
DIS
|
+$193M |
| 3 |
Advanced Micro Devices
AMD
|
+$165M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
MarketAxess Holdings
MKTX
|
+$148M |
Sector Composition
| 1 | Technology | 23.05% |
| 2 | Healthcare | 13.44% |
| 3 | Financials | 13.33% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMTD
2651
AMTD IDEA Group
AMTD
$91.5M
| $97.5K | ﹤0.01% |
26,417
| – | – |
|
2652
Forge Global Holdings
FRGE
$231M
| $97K | ﹤0.01% |
+3,186
| New | +$97K |
|
2653
Monte Rosa Therapeutics
GLUE
$302M
| $94.9K | ﹤0.01% |
19,814
+6,879
| +53% | +$33K |
|
|
SRTA
2654
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$326M
| $94.5K | ﹤0.01% |
36,499
+24,968
| +217% | +$64.7K |
|
2655
MannKind Corp
MNKD
$1.71B
| $93.4K | ﹤0.01% |
22,609
| – | – |
|
2656
Olaplex Holdings
OLPX
$941M
| $92.5K | ﹤0.01% |
47,448
+17,521
| +59% | +$34.2K |
|
2657
Tenaya Therapeutics
TNYA
$209M
| $91.8K | ﹤0.01% |
35,994
+15,117
| +72% | +$38.5K |
|
|
KC
2658
Kingsoft Cloud Holdings
KC
$4.58B
| $91.7K | ﹤0.01% |
18,592
-49,049
| -73% | -$242K |
|
2659
SelectQuote
SLQT
$339M
| $91K | ﹤0.01% |
77,817
+31,480
| +68% | +$36.8K |
|
2660
Origin Materials
ORGN
$81.4M
| $88.6K | ﹤0.01% |
69,188
+16,626
| +32% | +$21.3K |
|
2661
Immuneering
IMRX
$341M
| $87.9K | ﹤0.01% |
+11,450
| New | +$87.9K |
|
2662
908 Devices
MASS
$206M
| $86.6K | ﹤0.01% |
+13,007
| New | +$86.6K |
|
2663
CS Disco
LAW
$343M
| $86.2K | ﹤0.01% |
+12,984
| New | +$86.2K |
|
2664
Ranpak Holdings
PACK
$416M
| $85.5K | ﹤0.01% |
15,721
+5,099
| +48% | +$27.7K |
|
2665
Zevra Therapeutics
ZVRA
$448M
| $85.2K | ﹤0.01% |
17,679
+4,199
| +31% | +$20.2K |
|
2666
Ponce Financial Group
PDLB
$334M
| $81.6K | ﹤0.01% |
+10,438
| New | +$81.6K |
|
2667
Broadwind
BWEN
$52.8M
| $81.1K | ﹤0.01% |
25,341
-1,298
| -5% | -$4.15K |
|
2668
Hippo Holdings
HIPO
$891M
| $80.8K | ﹤0.01% |
+10,141
| New | +$80.8K |
|
2669
Custom Truck One Source
CTOS
$1.29B
| $80.7K | ﹤0.01% |
13,013
+2,103
| +19% | +$13K |
|
2670
Erasca
ERAS
$440M
| $79.6K | ﹤0.01% |
40,410
+11,304
| +39% | +$22.3K |
|
2671
Fate Therapeutics
FATE
$118M
| $78.6K | ﹤0.01% |
37,062
+15,848
| +75% | +$33.6K |
|
2672
Seer Inc
SEER
$117M
| $78.5K | ﹤0.01% |
35,522
+9,456
| +36% | +$20.9K |
|
2673
SkyWater Technology
SKYT
$474M
| $78.4K | ﹤0.01% |
+13,019
| New | +$78.4K |
|
2674
Leslie's
LESL
$62M
| $76.9K | ﹤0.01% |
13,583
+77
| +0.6% | +$436 |
|
|
INZY
2675
DELISTED
Inozyme Pharma
INZY
| $75.9K | ﹤0.01% |
18,073
+5,873
| +48% | +$24.7K |
|